This indicates that even though AML cells are completely resistant to rhTRAIL WT, they are sensitive to DR4-specific TRAIL variants, which is similar to the CLL cells described above [76]. This evidence concerns the gene TNFSF10 and B-cell chronic lymphocytic leukemia.